We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.
- Authors
du Bois, Andreas; Lück, Hans-Joachim; Meier, Werner; Adams, Hans-Peter; Möbus, Volker; Costa, Serban; Bauknecht, Thomas; Richter, Barbara; Warm, Matthias; Schröder, Willibald; Olbricht, Sigrid; Nitz, Ulrike; Jackisch, Christian; Emons, Günther; Wagner, Uwe; Kuhn, Walther; Pfisterer, Jacobus; Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group
- Abstract
Despite considerable improvement in the treatment of advanced ovarian cancer, the optimization of efficacy and tolerability remains an important issue. Therefore, we performed a randomized, phase III non-inferiority trial comparing paclitaxel plus cisplatin (PT) with paclitaxel plus carboplatin (TC) in patients with advanced ovarian cancer.
- Publication
Journal of the National Cancer Institute, 2003, Vol 95, Issue 17, p1320
- ISSN
1460-2105
- Publication type
Journal Article
- DOI
10.1093/jnci/djg036